Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up.
Geraldine Cancel-TassinM RoupretU PinarC GafforyF VanieV OndetE CompératOlivier CussenotPublished in: World journal of urology (2021)
Xpert BC Monitor performance was superior to that of cytology in the follow-up of NMIBC. The exclusion of aggressive tumours with a very high NPV (99.7%) supports the use of this urinary test in daily practice.